PEPTIMIMESIS
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors. PeptiMimesis will develop its pipeline against key targets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
PEPTIMIMESIS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2015-10-01
Address:
Illkirch, Alsace, France
Country:
France
Website Url:
http://www.peptimimesis.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cap Innov'Est
Cap Innov'Est investment in Seed Round - PeptiMimesis
Cap Innov'Est
Cap Innov'Est investment in Seed Round - PeptiMimesis
Official Site Inspections
http://www.peptimimesis.com
- Host name: redirect.ovh.net
- IP address: 213.186.33.5
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
